HIV-1 Vif: a guardian of the virus that opens up a new era in the research field of restriction factors

被引：8

作者：

Takaori-Kondo, Akifumi ^{[1
]}

Shindo, Keisuke ^{[1
]}

机构：

[1] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto 6068507, Japan

来源：

FRONTIERS IN MICROBIOLOGY | 2013年 / 4卷

关键词：

HIV-1; Vif; restriction factor; ubiquitin ligase; cell cycle arrest; p53; MDM2; HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1; VIF; CELL-CYCLE; ANTIVIRAL ACTIVITY; VIRAL INFECTIVITY; ENZYME APOBEC3G; SOR GENE; SOCS-BOX; CBF-BETA; I VIF;

D O I：

10.3389/fmicb.2013.00034

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The research on virion infectivity factor (Vif) protein had started in late 1980s right after HIV-1 was cloned, and the function of Vif had been a mystery for a long time. However, the research on Vif has finally lead to the identification of APOBEC3G, which opens up a new era in the research field of host restriction factors in HIV-1 infection followed by TRIM5 alpha, Tetherin/BST-2, and SAMHD1. This suggests that continuation of basic research on fundamental questions is quite important. We still have many questions on Vif and APOBEC3 and should continue to work on these proteins in the future in order to better regulate HIV-1. We will discuss not only the history but also recent advances in Vif research.

引用

页数：5

共 59 条

[1] High level expression of human immunodeficiency virus type-1 Vif inhibits viral infectivity by modulating proteolytic processing of the gag precursor at the p2/nucleocapsid processing site [J].

Akari, H ;

Fujita, M ;

Kao, S ;

Khan, MA ;

Shehu-Xhilaga, M ;

Adachi, A ;

Strebel, K .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) :12355-12362

[2] A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor [J].

Bogerd, HP ;

Doehle, BP ;

Wiegand, HL ;

Cullen, BR .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (11) :3770-3774

[3] Characterization of human immunodeficiency virus type 1 Vif particle incorporation [J].

Camaur, D ;

Trono, D .

JOURNAL OF VIROLOGY, 1996, 70 (09) :6106-6111

[4]

Chen G., 2009, J VIROL, V83, P8674

[5] Identification of a Novel WxSLVK Motif in the N Terminus of Human Immunodeficiency Virus and Simian Immunodeficiency Virus Vif That Is Critical for APOBEC3G and APOBEC3F Neutralization [J].

Dang, Ying ;

Wang, Xiaojun ;

Zhou, Tao ;

York, Ian A. ;

Zheng, Yong-Hui .

JOURNAL OF VIROLOGY, 2009, 83 (17) :8544-8552

[6] Identification of highly attenuated mutants of simian immunodeficiency virus [J].

Desrosiers, RC ;

Lifson, JD ;

Gibbs, JS ;

Czajak, SC ;

Howe, AYM ;

Arthur, LO ;

Johnson, RP .

JOURNAL OF VIROLOGY, 1998, 72 (02) :1431-1437

[7] The Vif protein of human immunodeficiency virus type 1 is posttranslationally modified by ubiquitin [J].

Dussart, S ;

Courcoul, M ;

Bessou, G ;

Douaisi, M ;

Duverger, Y ;

Vigne, R ;

Decroly, E .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 315 (01) :66-72

[8] THE SOR GENE OF HIV-1 IS REQUIRED FOR EFFICIENT VIRUS TRANSMISSION INVITRO [J].

FISHER, AG ;

ENSOLI, B ;

IVANOFF, L ;

CHAMBERLAIN, M ;

PETTEWAY, S ;

RATNER, L ;

GALLO, RC ;

WONGSTAAL, F .

SCIENCE, 1987, 237 (4817) :888-893

[9] Expression of HIV-1 accessory protein Vif is controlled uniquely to be low and optimal by proteasome degradation [J].

Fujita, M ;

Akari, H ;

Sakurai, A ;

Yoshida, A ;

Chiba, T ;

Tanaka, K ;

Strebel, K ;

Adachi, A .

MICROBES AND INFECTION, 2004, 6 (09) :791-798

[10] ROLE OF VIF IN REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN CD4+ T LYMPHOCYTES [J].

GABUZDA, DH ;

LAWRENCE, K ;

LANGHOFF, E ;

TERWILLIGER, E ;

DORFMAN, T ;

HASELTINE, WA ;

SODROSKI, J .

JOURNAL OF VIROLOGY, 1992, 66 (11) :6489-6495

← 1 2 3 4 5 6 →